← Open Payments lookup

SYLVIA BUSTAMANTE: Open Payments

NPI 1891980223 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,581 in 65 payments from 10 companies in 2025. Trend: 2023 $733 · 2024 $1,060 · 2025 $1,581

Food & beverage: $1,581
CompanyPaymentsAmount
Abbott Laboratories13$478
Novo Nordisk Inc15$293
Lilly USA, LLC15$293
ABBVIE INC.7$156
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$145
PFIZER INC.3$76
Exact Sciences Corporation3$58
AstraZeneca Pharmaceuticals LP2$33
Amgen Inc.2$29
Inspire Medical Systems, Inc.1$21

Products named: FREESTYLE LIBRE 3, Wegovy, XIFAXAN, ZEPBOUND, MOUNJARO, ELIQUIS, VRAYLAR, JARDIANCE.

Industry payments across TX — which companies pay providers there.